Drrx stock forecast.

A. The latest price target for Durect ( NASDAQ: DRRX) was reported by JonesTrading on Thursday, November 9, 2023. The analyst firm set a price target for 0.00 expecting DRRX to fall to within 12 ...Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.According to our current DRRX stock forecast, the value of DURECT shares will drop by -16.10% and reach $ 0.545352 per share by December 5, 2023. According to our …

Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...Astrotech's stock was trading at $9.99 at the beginning of 2023. Since then, ASTC shares have decreased by 20.9% and is now trading at $7.90. View the best growth stocks for 2023 here.

Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.

DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.Forecst.com predicts future values using technical analysis of a large number of analytical parameters. DRRX stock returns are also predicted based on historical data. According to our research, DRRX stock is a not so good long-term investment. DRRX share price has been in a bull cycle for the past year.On average, Wall Street analysts predict that Durect 's share price could reach $34.00 by Aug 10, 2024. The average Durect stock price prediction forecasts a potential upside …Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ...

Nov 27, 2023 · A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Real time Durect (DRRX) stock price quote, stock graph, news & analysis. DRVN one year forecast. Driven Brands Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DRVN stock forecast for 2023 – 2027. Last updated: June 22, 2023. Are you interested in Driven Brands Holdings Inc. stocks prediction?The latest Durect stock prices, stock quotes, news, and DRRX history to help you invest and trade smarter. ... Vanguard Total Stock Market ETF: 2.48: Armistice Capital LLC: 2.21: Vanguard Russell ...Get the latest Galera Therapeutics Inc (GRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Story continues. DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver ...Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.

DRRX Stock USD 6.40 0.02 0.31% Durect stock price prediction is an act of determining the future value of Durect shares using few different conventional methods such as EPS estimation , analyst consensus, or fundamental intrinsic valuation . According to . 2 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $34.00, with the highest DRRX stock price forecast at $41.00 and the lowest DRRX stock price forecast at $27.00. Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...The DRRX shares have gain 15.52% over the last week, with a monthly amount drifted -79.02%, and not seem to be holding Durect Corp [DRRX] stock prices are up 0.44% to $0.61 at the moment. One of the good ways to gauge the recent performance is if the stock's short-term value is rising or falling.

DIRTT Environmental Solutions Ltd. (DRTT) share price prediction for 2023, 2024, 2025, 2026 and 2027. DRTT one year forecast. DIRTT Environmental Solutions stock ...Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...

DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.BIOL Sales Forecast. Next quarter’s sales forecast for BIOL is $14.75M with a range of $13.35M to $16.70M. The previous quarter’s sales results were $10.92M. BIOL beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.06% of the time in the same period.Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Stock analysis for Durect Corp (DRRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ... DURECT · Dutch Bros · D-Wave Quantum · DXC Technology Company · DXP Enterprises · Dyadic International · Dycom Industries · Dynagas LNG Partners LP · Dynatrace.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Real time Durect (DRRX) stock price quote, stock graph, news & analysis.

DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%.DRRX Stock Price Forecast. The average stock forecast for DURECT Corp (DRRX) in the next 12 months is 30.40 USD. This price target corresponds to an upside of 10.83%. The range of stock forecasts for DRRX is 12.12 - 43.05 USD. …People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.DRRX, Durect - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. RESEARCH. Shopping Cart. Your cart is ... Durect (DRRX) - Develops pharmaceuticals for chronic pain and central nervous system disorders. GROUP LEADERSHIP Medical-Biomed/Biotech Group. DRRX. is not ranked …Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.Nov 14, 2023 · Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum. Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...DSAC stock forecast for 2023 – 2027. Last updated: November 22, 2023. Are you interested in Duddell Street Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the DSAC stock price in …Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

The forecasts range from a low of 32.32 to a high of $46.20. ... The put/call ratio of DRRX is 2.53, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27. ...It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow …Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trialInstagram:https://instagram. health insurance companies pennsylvanianew plane boeingliberty coin value 1979fidelity select biotechnology Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan... dutch bro stocksspy vs qqq Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week. what is the best financial planning software The Takeda Pharmaceutical 52-week low stock price is 13.19, which is 6.8% below the current share price. ... DURECT (DRRX), United States, $0.018B, 0.00. Jaguar ...Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.